Canada’s Right-Wing Think Tanks Love Race Science
By Mitchell Thompson,
Jacobin
| 04. 11. 2022
Photo of Charles Murray
by Gage Skidmore on Flickr
When right-wing governments across Canada slash social programs and protections, they turn to research institutes and think tanks who eagerly prepare policy papers to support them. It is this stratum of researchers and scholars who provide the ideological underpinning for conservative political strategy.
Starting in the 1970s, ongoing cuts have been made to Canada’s social assistance programs, leaving the country’s welfare net threadbare. The justifications for these cuts were often provided by right-wing think tanks who advanced the principle that the poor are innately inferior and undeserving of assistance. These rationales evince a passion for the ideas of Charles Murray and other social scientists whose policy advice hinges on racist pseudoscience. In their telling, the problems of social inequality can largely be explained by welfare mothers’ “illegitimate births” and the genetic inferiority of people of color.
A review of the proposals used by Canadian conservatives to gut social spending has found that the case made by these think tanks was based as much on a racist and classist worldview as on...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Michael Gibney, PharmaVoice | 03.20.2025
The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech innovation.
While gene therapies like Sarepta’s offer an opportunity to treat and...